A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors - Concepedia

Concepedia

Publication | Closed Access

A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors

46

Citations

25

References

2014

Year

Nuttapong Ngamphaiboon, Grace K. Dy, Wen Wee, Yujie Zhao, Thanyanan Reungwetwattana, Dawn DePaolo, Yi Ding, William E. Brady, Gerald J. Fetterly, Alex A. Adjei

Investigational New Drugs

Inhibitor EntinostatOncologyMedicinePathologyAdvanced Solid TumorsAnti-cancer AgentCancer TreatmentPharmacologyHistone DeacetylaseCancer ResearchTumor Biology

References

	Year	Citations

Page 1

Page 1